Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Comment
Polly Hudson

I found it agonising to quit smoking. So why are people ignoring the new treatments on offer?

Woman extinguishing cigarette in glass ashtray

If there was a five-minute nuclear warning, I’d run straight to my local shop and buy a pack of cigarettes. Even now, after all these years. I stopped more than a decade ago – note that I say “stopped” rather than “gave up” because the latter implies a sacrifice, and I have been brainwashed (OK, hypnotised) not to use the term. But you are never really a non-smoker. You are just a smoker who is currently not smoking. In your soul, you are forever one of the people who leave the table after eating to go and have a conversation outside, even if you physically stay put these days.

So, as someone who found it difficult to quit, it’s baffling to hear that although two stop-smoking medications have been available in the UK since 2024, only 0.2% of those attempting to give up have used them, according to an analysis of NHS data on smoking in England. Cytisine (which also goes by cytisinicline) is a plant-based product that has been used in eastern Europe since the 70s and may appeal to those who prefer a natural option over a synthetic drug. It mimics the effects of nicotine, and tricks your brain into thinking you’ve had a cigarette. Varenicline – withdrawn in 2021 over concerns about impurities, but now reformulated and rereleased – can apparently reduce the urge to smoke, make you enjoy it less when you do and ease withdrawal symptoms.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.